ARISAN THERAPEUTICS INC

Arisan Therapeutics Inc. specializes in advanced biomedical research and development, focusing on the design, optimization, and preclinical evaluation of novel therapeutic candidates. Their core capabilities include molecular pharmacology, target validation, lead compound screening, and pharmacokinetic/pharmacodynamic modeling, with expertise in small molecule and biologic drug discovery platforms. The company applies structure-based drug design, high-throughput screening, and in vivo disease modeling to advance candidates from concept to IND-enabling studies. Key differentiators lie in their integrated approach to translational science, combining computational chemistry with robust preclinical validation to reduce attrition risk. Their technical proficiency spans assay development, toxicology profiling, and formulation science tailored for oncology, immunology, and neurodegenerative indications. No award history is available to infer specific agency engagements or contract patterns. Consequently, there is no demonstrable track record of work with federal departments or agencies based on provided data. The primary NAICS code 541715 indicates classification under “Research and Development in the Physical, Engineering, and Life Sciences,” which in practice reflects non-clinical pharmaceutical R&D services. The company is positioned within the biopharmaceutical innovation ecosystem, serving as a specialized R&D partner for early-stage therapeutics development, particularly in discovery-phase programs requiring deep scientific rigor and regulatory readiness. Arisan Therapeutics Inc. is structured as a small business (2L) with its primary operations based in Carlsbad, California, a recognized hub for biotechnology innovation. The company holds no government certifications, and its market presence is defined by its scientific expertise rather than formal contracting credentials. It operates as a niche provider in the life sciences R&D sector, leveraging its location in Southern California’s biotech corridor to access talent and collaborative research networks.